Filana Therapeutics (SAVA) Q3 2026 Earnings

5AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.92
-0.68
-0.45
-0.21

Details

Expected EPS
-0.225
Actual EPS
N/A
Surprise EPS
0.23
Surprise Percent
+100%

Description

Filana Therapeutics (SAVA) will report earnings of for Q3 2026 on August 05, 2026.

0 Comments

Share your thoughts